Axol Bioscience Ltd. has acquired Newcells Biotech Ltd. for an undisclosed amount. Newcells Biotech specializes in developing advanced predictive in vitro models, including retina, kidney, and lung tissue platforms. These gold-standard models are designed to accelerate drug discovery and development by providing critical data on product safety and efficacy, helping pharmaceutical companies confidently answer questions around their therapies' potential. Newcells' approach focuses on harnessing the power of predictive data to navigate preclinical stages efficiently and cost-effectively, aiming to maximize the potential for clinical and market success by reliably mimicking in vivo physiology.
This acquisition strategically enhances Axol Bioscience's capabilities within the complex drug discovery and development sector. By integrating Newcells' unique expertise and cutting-edge tissue model platforms, Axol Bioscience gains a significant expansion of its in vitro model offerings. The synergy between the two companies is expected to create a more comprehensive suite of solutions for clients, enabling them to obtain reliable data earlier in the development process. This move is aimed at improving the predictability of drug interactions, reducing the high attrition rates often seen in preclinical and clinical trials, and ultimately helping clients make assured decisions.
The combined entity will be better positioned to provide intelligent preclinical models that offer targeted solutions to complex problems in drug development. By delivering reliable data, the integrated company will help clients identify, avoid, and mitigate risks and failures, taking the guesswork out of drug development. This strategic consolidation is anticipated to help pharmaceutical partners save money, save time, and improve the chances of bringing safe and efficacious assets to patients. The acquisition underscores a commitment to advancing drug development through innovative and predictive scientific tools, ultimately aiming to get ahead of the game in therapy development.